Associate Sponsors

Co-sponsor

How a residential home provider is coming to aid of child cancer patients

The study has found that the environment plays a statistically significant role in outcomes of cancers like acute leukaemia which need intensive treatment

cancer
Photo: St Jude Child Care Centres
Geetanjali Krishna
4 min read Last Updated : Jan 17 2020 | 11:58 PM IST
A group of children joyfully sing nursery rhymes in a bright yellow room. Among them is three-and-a-half-year-old Saajan Pandey, naughty, active and difficult to pin down.

“Seven months ago when he was diagnosed with leukaemia, he was too weak to walk,” says his father Abhishek Pandey, a rural schoolteacher from Bihar’s Nalanda district. Pandey and his wife brought Saajan to the All India Institute of Medical Sciences, Delhi, for treatment.

“The doctors at AIIMS said there was a good chance Saajan would recover,” he says. But it meant having to stay in Delhi for at least eight months during the course of his treatment. For the cash-strapped Pandeys, such a long stay in Delhi was out of the question.

They barely managed to raise the Rs 250,000 required for Saajan’s treatment. Fortunately, the doctors at AIIMS referred them to St Jude India ChildCare Centres (SJICC), a unique organisation which runs residential homes for families of children who need to undergo long-term cancer treatment.

In 2006, SJICC founders Shyama and Nihal Kaviratne went to Tata Memorial Hospital in Mumbai and discovered young cancer patients registered with the hospital’s OPD for long-term treatment. They were often camping on the dirty pavements outside.

“Childhood cancers generally have a high rate of cure,” says Anil Nair, CEO of SJICC. “Doctors believe that with good nutrition and strict hygiene, almost 90 per cent of childhood cancers are treatable.” To give children a fighting chance against the disease the Kaviratnes decided to set up a holistic residential centre near Tata Memorial Hospital.

From one centre in 2006, SJICC today has 37 centres that support 459 families at a time, all close to the country’s premier hospitals such as AIIMS in Delhi, Christian Medical College in Vellore and Tata Memorial in Mumbai.

Every centre provides a 90-100 square-foot residential space for each patient and two family members, dry rations, transport to and from the hospital, counselling and educational and co-curricular activities for both parents and children. Each family cooks and eats in the shared kitchen. The families have to abide by strict cleanliness and hygiene guidelines. “With everything else taken care of, all we have to do is focus on our child’s recovery,” says Pandey.

Research shows the efficacy of this model. In 2019, Tata Memorial researchers studied the impact of the long-term holistic care enabled at St Jude, on the recovery rates in childhood cancers.

The study has found that the environment plays a statistically significant role in outcomes of cancers like acute leukaemia which need intensive treatment. It also found fewer relapses among children who received holistic care in SJICC. For parents too, the experience of staying at St Jude is therapeutic. They bond over shared experiences, learn to optimise the care they give to their child and, most of all, feel less anxious about the future.

As Pandey puts it: “My family is loving and supportive but can’t understand what it’s like to have a child with cancer. Here, I meet other parents like me and that’s a relief.”

SJICC plans to expand and reach out to at least 1,000 families by 2024. Their model is, however, resource- and capital-intensive. Each centre costs between Rs 36 lakh and Rs 40 lakh per annum to run. Their annual budget of over Rs 15 crore is covered by institutional and CSR funds.

The independent agency, CRISIL, has awarded SJICC the highest rating for voluntary organisations, which indicates robust delivery capability and high financial proficiency.

But it’s the smile on Saajan’s face as he plays with other children that says it all. “Having a child with cancer is the worst trauma a parent can undergo,” says Pandey as he watches his son. “But St Jude has given him a fighting chance.”

Learn more at www.stjudechild.org or follow them on Facebook


One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :cancer patientcancer drugChildhood cancerhealthWeekend Reads

Next Story